For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
VP, Technical Operations, Cell and Gene Therapy
Rajiv joined Parexel in 2022, bringing more than 16 years of biopharmaceutical experience in CMC/technical operations for early- and late-stage development of biotherapeutics. His areas of expertise include bioprocess and analytical development for gene therapies and vaccines, including management and oversight of cGMP manufacturing of clinical trial material. Prior to Parexel, he has held multiple senior leadership positions, including Chief Technology Officer at SparingVision, Senior Director and Head of CMC at Voyager Therapeutics, Director of Biopharmaceutical Development at Genocea Biosciences and Head of Protein Sciences at LakePharma.
Rajiv earned his PhD in Life Sciences from Mumbai University and completed his postdoctoral research at New Jersey Medical School and Harvard University.